Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : CDC Endorses Booster Doses of Moderna, J&N COVID-19 Vaccines

10/22/2021 | 04:36am EST


© MT Newswires 2021
All news about MODERNA, INC.
05:26pHealth Care Up As Moderna Surges On Vaccine Anticipation -- Health Care Roundup
DJ
05:12pSCIENTISTS SCRAMBLE TO UNDERSTAND CO : What we know
AQ
05:01pWall Street rebounds after virus-related sell-off
RE
04:47pUS Stocks Rebound Monday After Friday's Sell-Off as Megacap Techs Lead
MT
04:37pU.S. CDC says all adults 18 and over should get COVID-19 booster shots
RE
04:22pNew variant cause for concern, not panic, Biden tells US
AQ
04:19pU.S. CDC says all adults 18 and over should get COVID-19 booster shots
RE
04:13pUS Stocks Rebound Monday, Paring Friday's Heavy Losses as Megacap Techs Lead
MT
04:00pWall Street rebounds after virus-related sell-off
RE
03:37pSOCIAL BUZZ : Moderna, Nvidia Two Most Mentioned Wallstreetbets Stocks; Tesla, Canoo Gain
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 449 M - -
Net income 2021 11 169 M - -
Net cash 2021 12 344 M - -
P/E ratio 2021 12,5x
Yield 2021 -
Capitalization 134 B 134 B -
EV / Sales 2021 6,95x
EV / Sales 2022 5,38x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 329,63 $
Average target price 272,53 $
Spread / Average Target -17,3%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.81%24 431
ALNYLAM PHARMACEUTICALS, INC.45.06%22 548